Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LOCALLY ADVANCED RECTAL CANCER”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07528209
What this trial is testing

Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerpMMR (Microsatellite Stable Rectal Cancer)
Sun Yat-sen University 556
Testing effectiveness (Phase 2)UnknownNCT04663763
What this trial is testing

Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Zhejiang Cancer Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06542588
What this trial is testing

Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy, HLX07and Serplulimab in LARC

Who this might be right for
Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 29
Testing effectiveness (Phase 2)UnknownNCT03561142
What this trial is testing

Organ Preservation in Locally Advanced Rectal Cancer by Radiochemotherapy Followed by Consolidation Chemotherapy.

Who this might be right for
Rectal CancerRectal NeoplasmsRectal Cancer Stage II+1 more
University Hospital Tuebingen 94
Not applicableUnknownNCT03601156
What this trial is testing

Preoperative Intraarterial Chemoembolization Combined With Radiotherpy in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Third Military Medical University 204
Early research (Phase 1)UnknownNCT06300489
What this trial is testing

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Zhejiang Cancer Hospital 30
Not applicableStudy completedNCT04271657
What this trial is testing

RadioPathomics Artificial Intelligence Model to Predict nCRT Response in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Testing effectiveness (Phase 2)UnknownNCT03503630
What this trial is testing

Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma

Who this might be right for
Locally Advanced Rectal Cancer
Ali Shamseddine 44
Early research (Phase 1)Active Not RecruitingNCT06464692
What this trial is testing

Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Adizutecan (ABBV-400) Moves Through the Body of Adult Participants With Unresectable Locally Advanced/Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
AbbVie 31
Testing effectiveness (Phase 2)Ended earlyNCT01347645
What this trial is testing

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Eisai Inc. 82
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314528
What this trial is testing

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer PatientsObesity &Amp; OverweightLocally Advanced Rectal Cancer (LARC)+2 more
St. James's Hospital, Ireland 42
Early research (Phase 1)Looking for participantsNCT07540572
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

Who this might be right for
ER+, HER 2- Breast CancerNon-small Cell Lung Cancer (NSCLC)Castration-resistant Prostate Cancer (CRPC)+1 more
IDEAYA Biosciences 160
Testing effectiveness (Phase 2)Ended earlyNCT00353457
What this trial is testing

Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma

Who this might be right for
Rectal Cancer
Abramson Cancer Center at Penn Medicine 6
Large-scale testing (Phase 3)UnknownNCT02484040
What this trial is testing

Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer

Who this might be right for
Response to ToxinToxicityRecurrence
Jong Hoon Lee 370
Not applicableUnknownNCT03577808
What this trial is testing

Organoids in Predicting Chemoradiation Sensitivity on Rectal Cancer

Who this might be right for
OrganoidsRectal CancerChemoradiation
Zhen Zhang 80
Not applicableStudy completedNCT05495308
What this trial is testing

"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

Who this might be right for
Rectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage III+2 more
Hospital San Carlos, Madrid 4
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Testing effectiveness (Phase 2)Looking for participantsNCT05601505
What this trial is testing

Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaCirculating Tumor DNA
Peking Union Medical College Hospital 470
Early research (Phase 1)Looking for participantsNCT06500052
What this trial is testing

BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+2 more
Sichuan Baili Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT05450029
What this trial is testing

Neoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Yanhong Deng 51
Next Page